Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Rev Mol Diagn. 2006 Mar;6(2):145-52.

Affymetrix GeneChip system: moving from research to the clinic.

Author information

1
Genomics Laboratory, Wellcome Trust Centre for Human Genetics, Oxford University, Oxford, OX3 7BN, UK. ioannis.ragoussis@well.ox.ac.uk

Abstract

Affymetrix Inc.'s GeneChip technology has become the industry standard in microarray-based research. Due to the high density of content per array that can be achieved today (an industry leading 6.5 million features) the GeneChips can be used for high-throughput mutation detection, single nucleotide polymorphism genotyping, expression profiling and detection of chromosomal aberrations. This in turn opens the way for clinical applications in genetics, cytogenetics, pharmacogenetics, oncology and pathogen recognition. Establishing standards is a central issue in improving data quality and, in combination with automatic, easy-to-interpret reports, will form the basis of the clinical applicability. Future pricing policies and the resolving of ethical considerations will also dictate the technology's full translation from research into clinical laboratories.

PMID:
16512775
DOI:
10.1586/14737159.6.2.145
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center